| [1] |
石明芳, 曾江辉, 周元圆, 等. 24 158例人乳头瘤病毒基因检测结果分析[J]. 医学检验与临床, 2024, 35(4):5-8.
|
| [2] |
HAN M, LI J, AUSTIN M, et al. Human papillomavirus (HPV) 16 and 18/45 genotyping-directed follow-up of women with messenger RNA HPV-positive,cytology-negative cervical screening test results[J]. Am J Clin Pathol, 2020, 153(2):243-250.
DOI
URL
|
| [3] |
CHARAKORN C, THADANIPON K, CHAIJINDARATANA S, et al. The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma:a systematic review and meta-analysis[J]. Gynecol Oncol, 2018, 150(1):190-200.
DOI
URL
|
| [4] |
ZHANG J, QIN L, CHEN H M, et al. Overall survival,locoregional recurrence,and distant metastasis of definitive concurrent chemoradiotherapy for cervical squamous cell carcinoma and adenocarcinoma:before and after propensity score matching analysis of a cohort study[J]. Am J Cancer Res, 2020, 10(6):1808-1820.
|
| [5] |
LI X, XU C, YU Y, et al. Prediction of lymphovascular space invasion using a combination of tenascin-C,cox-2,and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma[J]. BMC Cancer, 2021, 21:866.
DOI
|
| [6] |
国家卫生健康委员会. 宫颈癌诊疗指南[S]. 北京: 人民卫生出版社, 2022.
|
| [7] |
ZHANG J, CHENG K, WANG Z. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China:a meta-analysis[J]. Arch Gynecol Obstet, 2020, 302(6):1329-1337.
DOI
|
| [8] |
LI J, GAO J J, LI N, et al. Distribution of human papillomavirus genotypes in western China and their association with cervical cancer and precancerous lesions[J]. Arch Virol, 2021, 166(3):853-862.
DOI
PMID
|
| [9] |
GUO C, DU H, BELINSON J L, et al. The prevalence and distribution of human papillomavirus among 10 867 Chinese Han women[J]. Infect Agent Cancer, 2021, 16(1):21.
DOI
|
| [10] |
LIU J, MA S, QIN C, et al. Prevalence and genotype distribution of human papillomavirus in Zhengzhou,China,in 2016[J]. Arch Virol, 2020, 165(3):731-736.
|
| [11] |
WEI F, GEORGES D, MAN I, et al. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide:a systematic analysis of the global literature[J]. Lancet, 2024, 404(10451):435-444.
DOI
URL
|
| [12] |
YUAN Y, CAI X, SHEN F, et al. HPV post-infection microenvironment and cervical cancer[J]. Cancer Lett, 2021, 497:243-254.
DOI
PMID
|
| [13] |
LEI J, PLONER A, ELFSTRÖM K M, et al. HPV vaccination and the risk of invasive cervical cancer[J]. N Engl J Med, 2020, 383(14):1340-1348.
DOI
URL
|
| [14] |
IBRAGIMOVA M, TSYGANOV M, SHPILEVA O, et al. HPV status and its genomic integration affect survival of patients with cervical cancer[J]. Neoplasma, 2018, 65(3):441-448.
DOI
PMID
|
| [15] |
徐露露, 张琴, 孙梅. HPV感染型别及多重感染与女性宫颈病变的关联性分析[J]. 蚌埠医学院学报, 2023, 48(5):637-640.
|
| [16] |
STROHL A E, MENDOZA G, GHANT M S, et al. Barriers to prevention:knowledge of HPV,cervical cancer,and HPV vaccinations among African American women[J]. Am J Obstet Gynecol, 2015, 212(1):65.e1-65.e5.
|